CEA-targeted CAR-T immunotherapy 
Welcome,         Profile    Billing    Logout  
  Companies    Products    Products    Diseases    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 012345678910
            
            
             
gene-modified anti-CEA T cells / Sorrento           
          
            
             
C-13-60 / Chongqing Precision Biotech           
          
            
             
Anti CEA/CD30 CAR-T / Shanghai First Song Therap           
          
            
             
A2B530 / A2 Biotherap           
          
            
             
Anti-CEA-CAR T / Huadao (Shanghai) Biopharmaceutical           
          
            
             
Anti-CEA-CAR T / Southwest Hospital